# Tempest Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 2, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 16:30 ET
- Period: not reported
- Accession: 0001193125-26-140271
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526140271/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312526140271/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312526140271/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-140271. Last ingested by Listed: Nov 3, 2026, 14:25 ET. No prices; not investment advice.